Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | LAP3 | P28838 | 2/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CETP | P11597 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | UBE2N | P61088 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19371537 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1TP53CYP2D6LMNA | |
| SCHEMBL2981844 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1TP53CYP2D6LMNA | |
| SCHEMBL2993823 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1TP53CYP2D6LMNA | |
| SCHEMBL957034 | 0.98 | OPRM1 (0.50) | OPRM1SPHK1TP53CYP2D6LMNA | |
| SCHEMBL16432326 | 0.94 | OPRM1 (0.43) | OPRM1SPHK1TP53CYP2D6LMNA | |
| SCHEMBL8586711 | 0.91 | OPRM1 (0.41) | OPRM1SPHK1TP53 | |
| Ammonia Solution, Strong SCHEMBL20421796 | 0.89 | OPRM1 (0.39) | OPRM1TP53 | |
| SCHEMBL5154702 | 0.86 | CPB2 (0.39) | OPRM1 | |
| SCHEMBL21409631 | 0.86 | CPB2 (0.39) | OPRM1 | |
| SCHEMBL21410655 | 0.86 | OPRM1 (0.41) | OPRM1SPHK1TP53CYP2D6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024088992-A1 | METHOD FOR MANUFACTURING A FIRE-RESISTANT COATING MADE OF ORGANOMINERAL SILICA | SAINT-GOBAIN GLASS FRANCE (FR) | 2024-05-02 | — | — | WO | claimed |
| EP-4294772-A1 | FIRE-RESISTANT GLAZING | Saint-Gobain Glass France (FR) | 2023-12-27 | — | — | EP | claimed |
| EP-4211194-A1 | ANTI-MICROBIAL SURFACES AND RELATED METHODS | NBD Nanotechnologies, Inc. (US) | 2023-07-19 | — | — | EP | claimed |
| WO-2022055965-A9 | ANTI-MICROBIAL SURFACES AND RELATED METHODS | Nbd Nanotechnologies Inc. (US) | 2022-05-27 | — | — | WO | claimed |
| WO-2022055965-A1 | ANTI-MICROBIAL SURFACES AND RELATED METHODS | Nbd Nanotechnologies Inc. (US) | 2022-03-17 | — | — | WO | claimed |
| EP-3931269-A1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | NBD Nanotechnologies, Inc. (US) | 2022-01-05 | — | — | EP | claimed |
| WO-2021183115-A1 | PROTECTIVE PANELS WITH ANTI-GLARE CERAMIC COATS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2021-09-16 | — | — | WO | claimed |
| EP-3801928-A1 | INVISIBLE FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | Nbd Nanotechnologies, Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| EP-3755673-A1 | ETCHED GLASS SURFACES WITH HYDROPHOBIC ALKOXYORGANOSILANES | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2020-12-30 | — | — | EP | claimed |
| US-20200277513-A1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | HENKEL AG & CO. KGAA (DE) | 2020-09-03 | — | — | US | claimed |
| US-9382290-B2 | Aptamer-modified polymeric materials for the binding of factors in a wound environment | KCI LICENSING, INC. (US) | 2016-07-05 | — | — | US | claimed |
| EP-3027234-A1 | OSTEOINDUCTIVE MATERIALS | The University of Liverpool (GB) | 2016-06-08 | — | — | EP | claimed |
| US-20160149207-A1 | SURFACE TREATED SILICON CONTAINING ACTIVE MATERIALS FOR ELECTROCHEMICAL CELLS | NEXEON LIMITED (GB) | 2016-05-26 | — | — | US | claimed |
| EP-2702068-B1 | APTAMER-MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF THERAPEUTIC FACTORS IN A WOUND ENVIRONMENT | KCI LICENSING INC (US) | 2015-07-29 | — | — | EP | claimed |
| WO-2015044188-A1 | METAL EFFECT PIGMENTS MODIFIED WITH A SILANE LAYER CONTAINING AT LEAST TWO DIFFERENT BIFUNCTIONAL SILANES | SCHLENK METALLIC PIGMENTS GMBH (DE) | 2015-04-02 | — | — | WO | claimed |
| WO-2015015189-A1 | OSTEOINDUCTIVE MATERIALS | THE UNIVERSITY OF LIVERPOOL (GB) | 2015-02-05 | — | — | WO | claimed |
| EP-2702068-A1 | APTAMER -MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF THERAPEUTIC FACTORS IN A WOUND ENVIRONMENT | KCI Licensing Inc. (US) | 2014-03-05 | — | — | EP | claimed |
| WO-2012149242-A1 | APTAMER -MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF THERAPEUTIC FACTORS IN A WOUND ENVIRONMENT | KCI LICENSING, INC. (US) | 2012-11-01 | — | — | WO | claimed |
| US-20120276039-A1 | APTAMER-MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF FACTORS IN A WOUND ENVIRONMENT | KCI LICENSING, INC. (US) | 2012-11-01 | — | — | US | claimed |
| WO-2010121130-A2 | MOLECULAR DELIVERY WITH NANOWIRES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-10-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120276039-A1 | APTAMER-MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF FACTORS IN A WOUND ENVIRONMENT | SDF4, CXCL12, PCLAF | OPRM1 2707/4885SPHK1 3600/4885TP53 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.